vs

Side-by-side financial comparison of Kellanova (K) and Solventum (SOLV). Click either name above to swap in a different company.

Kellanova is the larger business by last-quarter revenue ($3.3B vs $2.0B, roughly 1.6× Solventum). Kellanova runs the higher net margin — 9.5% vs 3.2%, a 6.3% gap on every dollar of revenue. On growth, Kellanova posted the faster year-over-year revenue change (0.8% vs -3.7%). Kellanova produced more free cash flow last quarter ($359.0M vs $32.0M). Over the past eight quarters, Solventum's revenue compounded faster (-0.4% CAGR vs -9.0%).

Kellanova, formerly known as the Kellogg Company, is an American multinational food manufacturing company owned by Mars Inc. headquartered in Chicago, Illinois. The renaming took effect on October 2, 2023, and the company's North American cereal operations were spun off to form the WK Kellogg Co at the same time.

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

K vs SOLV — Head-to-Head

Bigger by revenue
K
K
1.6× larger
K
$3.3B
$2.0B
SOLV
Growing faster (revenue YoY)
K
K
+4.5% gap
K
0.8%
-3.7%
SOLV
Higher net margin
K
K
6.3% more per $
K
9.5%
3.2%
SOLV
More free cash flow
K
K
$327.0M more FCF
K
$359.0M
$32.0M
SOLV
Faster 2-yr revenue CAGR
SOLV
SOLV
Annualised
SOLV
-0.4%
-9.0%
K

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
K
K
SOLV
SOLV
Revenue
$3.3B
$2.0B
Net Profit
$309.0M
$63.0M
Gross Margin
33.3%
51.4%
Operating Margin
13.9%
6.3%
Net Margin
9.5%
3.2%
Revenue YoY
0.8%
-3.7%
Net Profit YoY
-15.8%
103.2%
EPS (diluted)
$0.88
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
K
K
SOLV
SOLV
Q4 25
$2.0B
Q3 25
$3.3B
$2.1B
Q2 25
$3.2B
$2.2B
Q1 25
$3.1B
$2.1B
Q4 24
$3.1B
$2.1B
Q3 24
$3.2B
$2.1B
Q2 24
$3.2B
$2.1B
Q1 24
$3.2B
$2.0B
Net Profit
K
K
SOLV
SOLV
Q4 25
$63.0M
Q3 25
$309.0M
$1.3B
Q2 25
$299.0M
$90.0M
Q1 25
$304.0M
$137.0M
Q4 24
$365.0M
$31.0M
Q3 24
$367.0M
$122.0M
Q2 24
$344.0M
$89.0M
Q1 24
$267.0M
$237.0M
Gross Margin
K
K
SOLV
SOLV
Q4 25
51.4%
Q3 25
33.3%
54.2%
Q2 25
34.0%
54.4%
Q1 25
34.3%
53.8%
Q4 24
37.7%
53.9%
Q3 24
36.4%
56.0%
Q2 24
36.4%
54.6%
Q1 24
32.2%
58.1%
Operating Margin
K
K
SOLV
SOLV
Q4 25
6.3%
Q3 25
13.9%
80.6%
Q2 25
13.7%
9.9%
Q1 25
13.9%
7.3%
Q4 24
17.0%
6.6%
Q3 24
14.1%
13.2%
Q2 24
15.4%
11.7%
Q1 24
12.3%
18.9%
Net Margin
K
K
SOLV
SOLV
Q4 25
3.2%
Q3 25
9.5%
60.4%
Q2 25
9.3%
4.2%
Q1 25
9.9%
6.6%
Q4 24
11.7%
1.5%
Q3 24
11.4%
5.9%
Q2 24
10.8%
4.3%
Q1 24
8.3%
11.8%
EPS (diluted)
K
K
SOLV
SOLV
Q4 25
$0.37
Q3 25
$0.88
$7.22
Q2 25
$0.85
$0.51
Q1 25
$0.87
$0.78
Q4 24
$1.05
$0.18
Q3 24
$1.05
$0.70
Q2 24
$1.00
$0.51
Q1 24
$0.78
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
K
K
SOLV
SOLV
Cash + ST InvestmentsLiquidity on hand
$240.0M
$878.0M
Total DebtLower is stronger
$4.3B
$5.0B
Stockholders' EquityBook value
$4.2B
$5.0B
Total Assets
$15.6B
$14.3B
Debt / EquityLower = less leverage
1.02×
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
K
K
SOLV
SOLV
Q4 25
$878.0M
Q3 25
$240.0M
$1.6B
Q2 25
$354.0M
$492.0M
Q1 25
$330.0M
$534.0M
Q4 24
$694.0M
$762.0M
Q3 24
$569.0M
$772.0M
Q2 24
$272.0M
$897.0M
Q1 24
$242.0M
$996.0M
Total Debt
K
K
SOLV
SOLV
Q4 25
$5.0B
Q3 25
$4.3B
$5.1B
Q2 25
$4.3B
$7.8B
Q1 25
$5.0B
$7.9B
Q4 24
$5.0B
$8.0B
Q3 24
$5.1B
$8.1B
Q2 24
$5.0B
$8.3B
Q1 24
$4.4B
$8.3B
Stockholders' Equity
K
K
SOLV
SOLV
Q4 25
$5.0B
Q3 25
$4.2B
$5.0B
Q2 25
$4.1B
$3.6B
Q1 25
$3.9B
$3.3B
Q4 24
$3.8B
$3.0B
Q3 24
$3.6B
$3.2B
Q2 24
$3.3B
$2.9B
Q1 24
$3.2B
$3.9B
Total Assets
K
K
SOLV
SOLV
Q4 25
$14.3B
Q3 25
$15.6B
$14.0B
Q2 25
$15.9B
$15.1B
Q1 25
$15.5B
$14.5B
Q4 24
$15.6B
$14.5B
Q3 24
$15.8B
$14.7B
Q2 24
$15.3B
$14.6B
Q1 24
$15.3B
$14.7B
Debt / Equity
K
K
SOLV
SOLV
Q4 25
1.00×
Q3 25
1.02×
1.03×
Q2 25
1.05×
2.14×
Q1 25
1.28×
2.43×
Q4 24
1.32×
2.71×
Q3 24
1.40×
2.54×
Q2 24
1.51×
2.90×
Q1 24
1.40×
2.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
K
K
SOLV
SOLV
Operating Cash FlowLast quarter
$503.0M
$95.0M
Free Cash FlowOCF − Capex
$359.0M
$32.0M
FCF MarginFCF / Revenue
11.0%
1.6%
Capex IntensityCapex / Revenue
4.4%
3.2%
Cash ConversionOCF / Net Profit
1.63×
1.51×
TTM Free Cash FlowTrailing 4 quarters
$599.0M
$-10.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
K
K
SOLV
SOLV
Q4 25
$95.0M
Q3 25
$503.0M
$76.0M
Q2 25
$169.0M
$169.0M
Q1 25
$116.0M
$29.0M
Q4 24
$467.0M
$219.0M
Q3 24
$553.0M
$169.0M
Q2 24
$376.0M
$355.0M
Q1 24
$364.0M
$442.0M
Free Cash Flow
K
K
SOLV
SOLV
Q4 25
$32.0M
Q3 25
$359.0M
$-21.0M
Q2 25
$21.0M
$59.0M
Q1 25
$-60.0M
$-80.0M
Q4 24
$279.0M
$92.0M
Q3 24
$410.0M
$76.0M
Q2 24
$234.0M
$297.0M
Q1 24
$209.0M
$340.0M
FCF Margin
K
K
SOLV
SOLV
Q4 25
1.6%
Q3 25
11.0%
-1.0%
Q2 25
0.7%
2.7%
Q1 25
-1.9%
-3.9%
Q4 24
8.9%
4.4%
Q3 24
12.7%
3.7%
Q2 24
7.3%
14.3%
Q1 24
6.5%
16.9%
Capex Intensity
K
K
SOLV
SOLV
Q4 25
3.2%
Q3 25
4.4%
4.6%
Q2 25
4.6%
5.1%
Q1 25
5.7%
5.3%
Q4 24
6.0%
6.1%
Q3 24
4.4%
4.5%
Q2 24
4.4%
2.8%
Q1 24
4.8%
5.1%
Cash Conversion
K
K
SOLV
SOLV
Q4 25
1.51×
Q3 25
1.63×
0.06×
Q2 25
0.57×
1.88×
Q1 25
0.38×
0.21×
Q4 24
1.28×
7.06×
Q3 24
1.51×
1.39×
Q2 24
1.09×
3.99×
Q1 24
1.36×
1.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

K
K

Retail Channel Snacks$2.0B62%
Retail Channel Cereal$678.0M21%
Noodlesand Other$280.0M9%
Frozen And Specialty Channels$275.0M8%

SOLV
SOLV

Infection Prevention And Surgical Solutions$752.0M38%
Cost Of Software And Rentals$508.0M25%
Health Information Systems Segment$347.0M17%
Dental Solutions Segment$343.0M17%
Related Party$14.0M1%

Related Comparisons